Moreover, OS was significantly different and mimicked the outcome of the corresponding MDS/MPN counterpart, with the ‘MDS/MPN-RS-T-like’ category being associated with the highest median OS and the patients within ‘TP53’ group having the most unfavorable prognosis (Table 2). This evidence concerns the gene TP53 and myeloproliferative disorder.